LexaGene Provides Update on Commercializing its Automated Pathogen Detection System
June 01, 2020 08:49 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”) a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory
May 28, 2020 07:55 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Holdings Receives Approval to Amend Warrant Terms
May 08, 2020 22:36 ET
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., May 08, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB:...
LexaGene Holdings Proposes to Amend Warrants Terms and Announces a Strategic Marketing Promotional Campaign
April 23, 2020 17:00 ET
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB:...
LexaGene Files Patent Application for Expanded Capabilities of Their LX Analyzer
April 16, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Appoints Dr. Eleanor Kolossovski to Director of Product Marketing
April 01, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Appoints Steven Armstrong to Senior Director of Operations
March 24, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., March 24, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Provides Update on the Exercise of Warrants
March 17, 2020 15:07 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Provides Corporate Update
March 11, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene’s LX Analyzer Successfully Detects Coronavirus RNA using the CDC’s Tests
February 20, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a biotechnology company that develops genetic analyzers for...